| Trial ID: | L0164 |
| Source ID: | NCT01975935
|
| Associated Drug: |
Amlexanox
|
| Title: |
Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
Has Results
|
| Results: |
https://ClinicalTrials.gov/show/NCT01975935/results
|
| Conditions: |
Diabetes Mellitus Type 2|Non-alcoholic Fatty Liver Disease|Obesity
|
| Interventions: |
Drug: Amlexanox|Drug: Placebo
|
| Outcome Measures: |
Difference in Hemoglobin A1c Values|Hepatic Steatosis as Measured by MRI|Change in Weight
|
| Sponsor/Collaborators: |
University of Michigan
|
| Gender: |
All
|
| Age: |
18 Years and older ?? (Adult, Older Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
42
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment
|
| Start Date: |
January 2014
|
| Completion Date: |
August 18, 2017
|
| Results First Posted: |
May 9, 2017
|
| Last Update Posted: |
November 7, 2018
|
| Locations: |
University of Michigan, Ann Arbor, Michigan, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT01975935
|
